PAF Acetylhydrolase Isoform 1B Complex: A Drug Target for Platelet-related Disorders

Target Name: Platelet-activating factor acetylhydrolase isoform 1B complex

NCBI ID: P10214

Platelet-activating factor acetylhydrolase isoform 1B complex

Other Name(s): PAF acetylhydrolase | Platelet-Activating Factor Acetylhydrolase Ib | PAFAH Ib | PAF-AH IB

PAF Acetylhydrolase Isoform 1B Complex: A Drug Target for Platelet-related Disorders

Platelet-activating factor (PAF) acetylhydrolase isoform 1B complex is a protein that plays a crucial role in the regulation of platelet function. It is a protein complex that consists of multiple subunits that are located in the cytosol of cells. The main function of this protein is to regulate the acetylation of the regulatory protein tyrosine, which is involved in the regulation of many cellular processes.

PAF acetylhydrolase isoform 1B complex isoform is a protein that is expressed in various tissues and cells, including platelets, endothelial cells, and epithelial cells. It is highly expressed in platelets, which are responsible for blood clotting. This protein is also expressed in other cells types, including cancer cells, which may contribute to its role in platelet-mediated signaling pathways.

One of the key functions of PAF acetylhydrolase isoform 1B complex is to regulate the acetylation of tyrosine, which is a post-translational modification that involves the addition of an acetyl group to the amino acid residue. This modification is involved in the regulation of many cellular processes, including cell signaling pathways, DNA replication, and protein function.

PAF acetylhydrolase isoform 1B complex isoform is also involved in the regulation of the levels of many different proteins in cells. For example, it has been shown to regulate the levels of the protein tyrosine kinase (TK) in platelets, which is involved in the regulation of many cellular processes. This suggests that PAF acetylhydrolase may be a drug target (or biomarker) for the treatment of platelet-related disorders.

In addition to its role in regulating tyrosine levels, PAF acetylhydrolase isoform 1B complex isoform is also involved in the regulation of many different cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, cell migration, and the formation of blood vessels. This suggests that this protein may be a useful target for the development of new therapies for various diseases.

PAF acetylhydrolase isoform 1B complex isoform is also a protein that is targeted by many different drugs in the treatment of various diseases. For example, inhibitors of PAF acetylhydrolase have been shown to be effective in the treatment of platelet-related disorders, such as thrombosis and bleeding disorders. These drugs work by inhibiting the activity of PAF acetylhydrolase, which in turn regulates the levels of tyrosine and platelet function.

In conclusion, PAF acetylhydrolase isoform 1B complex is a protein that plays a crucial role in the regulation of platelet function. It is highly expressed in platelets and other cell types, and is involved in the regulation of many cellular processes, including tyrosine acetylation and the regulation of cell adhesion, migration and formation of blood vessels. It is also a target for many different drugs in the treatment of various diseases, including platelet-related disorders. Further research is needed to fully understand the role of PAF acetylhydrolase isoform 1B complex in the regulation of platelet function and its potential as a drug target.

Protein Name: Platelet-activating Factor Acetylhydrolase Isoform 1B Complex

The "Platelet-activating factor acetylhydrolase isoform 1B complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Platelet-activating factor acetylhydrolase isoform 1B complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets